| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/12/2001 | US6245742 Antitumor, anticarcinogenic and antimetastasis agents; viricides, psoriasis, antiinflammatory agents, antiallergens, psoriasis |
| 06/12/2001 | US6245741 Protein Z-dependent protease inhibitor |
| 06/12/2001 | US6245739 polypeptides and polypeptide analogues |
| 06/12/2001 | US6245738 Cytokine restraining agents |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245562 Determining chromosomal breakpoint gene other than the immunoglobulin gene which is located in chromosome 14; complex between probe and the mrna; multiple myeloma |
| 06/12/2001 | US6245560 Vector with multiple target response elements affecting gene expression |
| 06/12/2001 | US6245550 Nucleotide sequence from gene homologous to erythropoetin and growth hormone; diagnosis; therapy of blood disorders, developmental/growth defects, and obesity; anti-inflammatory, antidiabetic, anticarcinogenic agents |
| 06/12/2001 | US6245549 Culturing virus from paramyxoviridae family in media free of exogenous serum proteins, isolating virus, solubilizing envelope glycoproteins; using affinity chromotography to isolate/purify immunogenic envelope glycoproteins; infants |
| 06/12/2001 | US6245544 An isolated polypeptide having a specific amino acid sequence; antiproliferative, anticarcinogenic, antitumor, antiarthritic, antiinflammatory agents; metastatsis; psoriasis; vision defects |
| 06/12/2001 | US6245532 Baculovirus signal peptide; for the development of therapy for prevention of viral disease |
| 06/12/2001 | US6245531 Polynucleotide encoding insect ecdysone receptor |
| 06/12/2001 | US6245530 Receptor ligand |
| 06/12/2001 | US6245529 Testis-specific cystatin-like protein cystatin T |
| 06/12/2001 | US6245527 Nucleotide sequence which encodes preferential platelet receptors; for the diagnosis and treatment of atherosclerosis, cardiovascular disorders and tumor metastasis; antitumor agents |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | US6245525 Tumor associated nucleic acids and uses therefor |
| 06/12/2001 | US6245523 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/12/2001 | US6245515 Double stranded dna fragment which has a p53 specific binding site and is covalently attached to insoluble polymer support |
| 06/12/2001 | US6245512 Promoter for VEGF receptor |
| 06/12/2001 | US6245510 Isolating preferential plant nucleotide sequences; incubate plant nucleotide sequences with probe, isolate hybridization products |
| 06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/12/2001 | US6245338 OMP26 antigen from Haemophilus influenzae |
| 06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
| 06/12/2001 | US6245335 Choline binding proteins for anti-pneumococcal vaccines |
| 06/12/2001 | US6245334 Polypeptide containing lecithin |
| 06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
| 06/12/2001 | US6245293 Cleaning and maintaining a drain pan in an air handling system |
| 06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
| 06/12/2001 | CA2092717C Expression of g protein coupled receptors in yeast |
| 06/12/2001 | CA2070831C Dna, constructs, cells and plants derived therefrom |
| 06/12/2001 | CA2060505C Method for recovering recombinant proteins |
| 06/12/2001 | CA2050058C Recombinant mite allergen |
| 06/12/2001 | CA1341253C Human ifn-.beta.2/il-6, its purification and use |
| 06/12/2001 | CA1341252C Human interferon-.beta.2a and interferon-.beta.2b; vectors containing genes coding for said interferons: cell lines producing same and use of said interferons as pharmaceuticals |
| 06/12/2001 | CA1341251C Pox virus vectors |
| 06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
| 06/09/2001 | CA2325766A1 Novel nucleotide sequences coding for the zwa2 gene |
| 06/07/2001 | WO2001040755A2 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 06/07/2001 | WO2001040521A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | WO2001040519A2 Methods for identifying modulators for balance related disorders |
| 06/07/2001 | WO2001040514A1 Method of judging flocculating properties of bottom brewer's yeast |
| 06/07/2001 | WO2001040512A2 Resistance gene |
| 06/07/2001 | WO2001040493A2 Schizophrenia associated gene, proteins and biallelic markers |
| 06/07/2001 | WO2001040491A2 Udp-glucose:aglycon-glucosyltransferase |
| 06/07/2001 | WO2001040490A2 Eukaryotic initiation factor 4e inhibitors and their use as herbicides |
| 06/07/2001 | WO2001040488A1 Increased transgene expression in retroviral vectors having scaffold attachment region |
| 06/07/2001 | WO2001040485A1 Novel polypeptide-ef-chiral calcium-binding protein 62 containing atp/gtp binding structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040481A1 Novel polypeptide -- human neuro:transmitter co-transporter membrane protein 13 and polynucleotide encoding it |
| 06/07/2001 | WO2001040479A1 Novel polypeptide, ef-chiral calcium-binding protein 96 containing atp/gtp binding structural domain and polynucleotide encoding it |
| 06/07/2001 | WO2001040476A2 Bacillus thuringiensis toxin active against formicidae (ant) |
| 06/07/2001 | WO2001040475A2 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 06/07/2001 | WO2001040474A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 06/07/2001 | WO2001040473A2 Pseudomonas aeruginosa antigens |
| 06/07/2001 | WO2001040472A2 Streptococcus pneumoniae antigens |
| 06/07/2001 | WO2001040471A1 Antigenic protein lppq of mycoplasma mycoidessubsp.(mycoides)sc., its preparation and use |
| 06/07/2001 | WO2001040470A1 Dna fragment having promoter function |
| 06/07/2001 | WO2001040469A2 Tick antigens and compositions and methods comprising them |
| 06/07/2001 | WO2001040468A2 Molecules of the card-related protein family and uses thereof |
| 06/07/2001 | WO2001040467A1 Human cytokine receptor |
| 06/07/2001 | WO2001040466A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2001 | WO2001040465A2 Compositions and methods for the treatment of immune related diseases |
| 06/07/2001 | WO2001040464A1 Interleukin-1-receptor associated kinase-3 (irak3) and its use in promotion or inhibition of angiogenesis and cardiovascularization |
| 06/07/2001 | WO2001040463A1 Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, dna encoding this protein and gene remedies containing the same for treating diseases associated with glycoprotein abnormality |
| 06/07/2001 | WO2001040461A2 Cdna sequence of two interactors fancip4 and fancip5 of the fanconi anaemia proteins of the complementation groups a and c |
| 06/07/2001 | WO2001040460A1 Screening method for compounds capable of modularing egr-1-regulated expression |
| 06/07/2001 | WO2001040457A1 Semaphorin receptor |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040439A2 CLONING AND EXPRESSION OF A DNA SEQUENCE ENCODING A 41 kDa CRYPTOSPORIDIUM PARVUM OOCYST WALL PROTEIN |
| 06/07/2001 | WO2001040438A2 Methods and compositions for regulating lymphocyte activity |
| 06/07/2001 | WO2001040313A2 Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 06/07/2001 | WO2001040312A2 Naive screening method |
| 06/07/2001 | WO2001040311A1 Chemokine slc-il2 fused protein and gene thereof |
| 06/07/2001 | WO2001040309A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/07/2001 | WO2001040305A1 Novel abcb9 transporter and uses thereof |
| 06/07/2001 | WO2001040304A1 Monkey orexin 2 receptor |
| 06/07/2001 | WO2001040303A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | WO2001040302A2 Organ transplant rejection and associated conditions |
| 06/07/2001 | WO2001040301A2 A gene, disrupted in schizophrenia |
| 06/07/2001 | WO2001040300A2 Protease resistant tumor suppressor p14(arf) |
| 06/07/2001 | WO2001040299A1 A novel polypeptide - human prolipoprotein signal peptide 14 and a polynucleotide encoding the same |
| 06/07/2001 | WO2001040297A1 A novel polypeptide - human atp/gtp binding domain-containing transition nuclear protein 10 and a polynucleotide encoding the same |
| 06/07/2001 | WO2001040296A1 A novel polypeptide - human cytochrome c domain-containing tnfr/ngfr protein 51 and a polynucleotide encoding the same |
| 06/07/2001 | WO2001040295A1 A new polypeptide - human zinc finger protein 48 and the polynucleotide encoding it |
| 06/07/2001 | WO2001040294A1 A novel polypeptide - human thrombospondin-30 and a polynucleoti de encoding the same |
| 06/07/2001 | WO2001040293A2 Method of modulating proapoptotic and antiapoptotic pathways in cells |
| 06/07/2001 | WO2001040292A1 Antigen-binding fragments specific for tumor associated antigens |
| 06/07/2001 | WO2001040291A2 Proteins and nucleic acids encoding the same |
| 06/07/2001 | WO2001040290A1 Immunogen, antivenom and vaccine against the venom of the black widow spider |
| 06/07/2001 | WO2001040289A1 A novel polypeptide - mitochondrial carrier 12 and polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040288A1 A novel polypeptide-human uteroglobin 13 and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040286A1 A human brain expressed x-linked protein and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040284A1 A novel polypeptide-human prolipoprotein signal peptide 11 and the polynucleotide encoding said polypeptide |
| 06/07/2001 | WO2001040282A1 Compositions isolated from m. vaccae and their use in the modulation of immune responses |
| 06/07/2001 | WO2001040281A2 Method for reducing the immunogenicity of heterologous proteins by elimination of t-cell epitopes |
| 06/07/2001 | WO2001040280A2 Composition and method for treating a microbial infection |
| 06/07/2001 | WO2001040279A2 Hbv sequences |
| 06/07/2001 | WO2001040278A2 Human semaphorin zsmf-16 |